Intrathecal administration of iopamidol in children: clinical and diagnostic results
- 41 Downloads
An open label, noncomparative clinical trial of intrathecal iopamidol in children was performed. Sixty-one subjects between the ages of 24 days and 17 years were studied. Opacification of the subarachnoid space was adequate in all cases. Mild adverse reactions were detected in 10% of the participants. Seizures, EEG alterations or other severe reactions did not occur. The findings confirm the efficacy and safety of iopamidol as an intrathecal contrast medium in pediatrics.
KeywordsPublic Health Clinical Trial Contrast Medium Adverse Reaction Subarachnoid Space
Unable to display preview. Download preview PDF.
- 1.Pettersson H, Fitz CR, Harwood-Nash CF, Armstrong E, Chuang SH (1982) Adverse reactions to myelography with metrizamide in infants, children and adolescents. Acta Radiol [Diagn] 23: 323Google Scholar
- 7.Keiffer SA, Binet EF, Davis DO et al (1984) Lumbar myelography with iohexol and metrizamide: a comparative multicenter prospective study. Radiology 151: 665Google Scholar
- 8.Tourtellotte WW, Haerer AE, Heller GL, Somers JE (1964) Post-lumbar puncture headaches. Charles C Thomas, SpringfieldGoogle Scholar